Payment overview · 2025
General Payments
$288.00
7 reported records · 3 companies
Healthcare provider profile · identity verified
Michael A Cromer, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · TAMPA, FL · NPI 1326006081
Verified facts
What the public records show
CMS Open Payments records show Michael A Cromer, M.D. received $288.00 in general payments during 2025 across 7 reported records.
ABBVIE INC. accounted for 63.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $182.81 | 63.5% | 5 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $90.00 | 31.2% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $15.19 | 5.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $288.00 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $175.35 | 4 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $90.00 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.19 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
55 | 12 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 626 | 189 |
| Lisinopril | Lisinopril | 481 | 145 |
| Amlodipine Besylate | Amlodipine Besylate | 470 | 137 |
| Levothyroxine Sodium | Levothyroxine Sodium | 442 | 136 |
| Alprazolam | Alprazolam | 402 | 84 |
| Metformin Hcl | Metformin Hcl | 379 | 113 |
| Losartan Potassium | Losartan Potassium | 338 | 113 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 328 | 121 |
| Omeprazole | Omeprazole | 303 | 99 |
| Gabapentin | Gabapentin | 300 | 94 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 268 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 265 | 87 |
| Simvastatin | Simvastatin | 243 | 69 |
| Prednisone | Prednisone | 233 | 139 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 223 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 209 | 63 |
| Tramadol Hcl | Tramadol Hcl | 196 | 45 |
| Lorazepam | Lorazepam | 184 | 38 |
| Carvedilol | Carvedilol | 181 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 172 | 56 |
| Eliquis | Apixaban | 163 | 38 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 162 | 50 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 158 | 50 |
| Trazodone Hcl | Trazodone Hcl | 152 | 44 |
| Clonazepam | Clonazepam | 141 | 33 |
| Furosemide | Furosemide | 140 | 55 |
| Metoprolol Tartrate | Metoprolol Tartrate | 140 | 46 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 137 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 128 | 34 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 123 | 88 |
| Duloxetine Hcl | Duloxetine Hcl | 123 | 34 |
| Ezetimibe | Ezetimibe | 118 | 37 |
| Pioglitazone Hcl | Pioglitazone Hcl | 118 | 32 |
| Donepezil Hcl | Donepezil Hcl | 117 | 36 |
| Famotidine | Famotidine | 117 | 37 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 117 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 112 | 44 |
| Temazepam | Temazepam | 112 | 22 |
| Allopurinol | Allopurinol | 108 | 37 |
| Montelukast Sodium | Montelukast Sodium | 106 | 38 |
| Meloxicam | Meloxicam | 105 | 39 |
| Ozempic | Semaglutide | 104 | 20 |
| Ibuprofen | Ibuprofen | 103 | 39 |
| Alendronate Sodium | Alendronate Sodium | 97 | 33 |
| Sertraline Hcl | Sertraline Hcl | 97 | 32 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 97 | 23 |
| Celecoxib | Celecoxib | 93 | 35 |
| Glimepiride | Glimepiride | 93 | 32 |
| Bupropion Xl | Bupropion Hcl | 89 | 32 |
| Finasteride | Finasteride | 89 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 87 | 26 |
| Propranolol Hcl | Propranolol Hcl | 83 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 82 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 81 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | 19 |
| Spironolactone | Spironolactone | 81 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 80 | 27 |
| Potassium Chloride | Potassium Chloride | 78 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 76 | 23 |
| Fenofibrate | Fenofibrate | 75 | 26 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 71 | 23 |
| Pregabalin | Pregabalin | 71 | 20 |
| Atenolol | Atenolol | 69 | 17 |
| Azithromycin | Azithromycin | 68 | 60 |
| Diazepam | Diazepam | 68 | 20 |
| Estradiol | Estradiol | 67 | 23 |
| Oxycodone Hcl | Oxycodone Hcl | 67 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 18 |
| Sildenafil Citrate | Sildenafil Citrate | 64 | 15 |
| Verapamil Er | Verapamil Hcl | 64 | 20 |
| Nifedipine Er | Nifedipine | 63 | 18 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 61 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 61 | 23 |
| Valsartan | Valsartan | 61 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 60 | 27 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 60 | 47 |
| Testosterone Cypionate | Testosterone Cypionate | 59 | 13 |
| Lovastatin | Lovastatin | 58 | 19 |
| Benazepril Hcl | Benazepril Hcl | 56 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 55 | 16 |
| Synthroid | Levothyroxine Sodium | 55 | 12 |
| Jardiance | Empagliflozin | 54 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 52 | 24 |
| Valacyclovir | Valacyclovir Hcl | 52 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 43 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 50 | suppressed |
| Mounjaro | Tirzepatide | 50 | 13 |
| Xarelto | Rivaroxaban | 50 | 13 |
| Memantine Hcl | Memantine Hcl | 47 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 46 | 11 |
| Januvia | Sitagliptin Phosphate | 46 | 12 |
| Naproxen | Naproxen | 45 | 19 |
| Bumetanide | Bumetanide | 43 | 15 |
| Morphine Sulfate Er | Morphine Sulfate | 41 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 41 | 41 |
| Sumatriptan Succinate | Sumatriptan Succinate | 41 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 40 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 37 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 37 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 28 |
| Nystatin | Nystatin | 36 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 18 |
| Progesterone | Progesterone, Micronized | 35 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Amoxicillin | Amoxicillin | 34 | 25 |
| Buspirone Hcl | Buspirone Hcl | 34 | 13 |
| Fluconazole | Fluconazole | 34 | 22 |
| Meclizine Hcl | Meclizine Hcl | 34 | 21 |
| Sucralfate | Sucralfate | 34 | 13 |
| Glipizide | Glipizide | 33 | suppressed |
| Ondansetron Odt | Ondansetron | 33 | 21 |
| Spiriva Respimat | Tiotropium Bromide | 33 | suppressed |
| Telmisartan | Telmisartan | 33 | suppressed |
| Trulicity | Dulaglutide | 32 | suppressed |
| Methocarbamol | Methocarbamol | 31 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 30 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 19 |
| Acyclovir | Acyclovir | 29 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Baclofen | Baclofen | 29 | 15 |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 28 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 28 | 14 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 28 | suppressed |
| Carisoprodol | Carisoprodol | 27 | suppressed |
| Linzess | Linaclotide | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Tadalafil | Tadalafil | 26 | suppressed |
| Anastrozole | Anastrozole | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Cephalexin | Cephalexin | 24 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Mirtazapine | Mirtazapine | 24 | 12 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 24 | 11 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 23 | suppressed |
| Premarin | Estrogens, Conjugated | 23 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 11 |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 12 |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Cefdinir | Cefdinir | 19 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | 12 |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Nabumetone | Nabumetone | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 15 |
| Testosterone | Testosterone | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Metronidazole | Metronidazole | 14 | 11 |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Clarithromycin | Clarithromycin | 13 | 12 |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 11 |
| Np Thyroid | Thyroid,pork | 12 | suppressed |
| Pioglitazone-Metformin | Pioglitazone Hcl/Metformin Hcl | 12 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Prolia | Denosumab | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $288.00 · 7 records | ABBVIE INC. | BOTOX, Cologuard Collection Kit, Dexcom G6 Transmitter | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error